STRUCTURED WARRANTS ANNOUNCEMENT : INITIAL OFFERING
DPHARMA-C6: CW DUOPHARMA BIOTECH BERHAD (KIBB) |
Type | Announcement |
Subject | STRUCTURED WARRANTS ANNOUNCEMENT INITIAL OFFERING |
Description | KENANGA INVESTMENT BANK BERHAD ("KIBB") PROPOSED ISSUE OF UP TO 35,000,000 EUROPEAN STYLE NON-COLLATERALISED CASH-SETTLED CALL WARRANTS OVER THE ORDINARY SHARES OF DUOPHARMA BIOTECH BERHAD ("DPHARMA") ("DPHARMA-C6") |
We are pleased to announce the proposed issue by KIBB of up to 35,000,000 European style non-collateralised cash-settled call warrants over the ordinary shares of DPHARMA.
The DPHARMA-C6 is constituted by the Deed Poll dated 19 May 2022 executed by us, as supplemented from time to time. The DPHARMA-C6 is subject to terms and conditions of the Base Prospectus dated 25 May 2022, the First Supplementary Base Prospectus dated 2 September 2022 and the Term Sheet dated 20 September 2022.
The DPHARMA-C6 will be listed on the Structured Warrants Board of Malaysia Securities Berhad and issued by KIBB under the Base Prospectus dated 25 May 2022 and the First Supplementary Base Prospectus dated 2 September 2022.
A summary of principal terms of the DPHARMA-C6 is set out in Table 1.
This announcement is dated 20 September 2022. |
Please refer attachment below.
Announcement Info
Company Name | DPHARMA-C6: CW DUOPHARMA BIOTECH BERHAD (KIBB) |
Stock Name | DPHARMA-C6 |
Date Announced | 20 Sep 2022 |
Category | General Announcement for PLC |
Reference Number | GA1-15092022-00049 |